YH001
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for YH001, covering 2023-09-21 to 2025-01-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Combination of YH003, YH001 and Pembrolizumab in Subjects with Advanced Solid Tumors [Phase 1]